Search

Louise Wang Zhiying Humphrey

Supervisory Patent Examiner (ID: 4289, Phone: (571)272-5543 , Office: P/1657 )

Most Active Art Unit
1648
Art Unit(s)
1657, 1648
Total Applications
627
Issued Applications
267
Pending Applications
54
Abandoned Applications
312

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7341584 [patent_doc_number] => 20040191272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Methods and reagents for vaccination which generate a CD8 T cell immune response' [patent_app_type] => new [patent_app_number] => 10/833745 [patent_app_country] => US [patent_app_date] => 2004-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19897 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20040191272.pdf [firstpage_image] =>[orig_patent_app_number] => 10833745 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/833745
Methods and reagents for vaccination which generate a CD8 T cell immune response Apr 27, 2004 Abandoned
Array ( [id] => 820332 [patent_doc_number] => 07407661 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-05 [patent_title] => 'Methods and reagents that generate a CD8 T cell immune response' [patent_app_type] => utility [patent_app_number] => 10/833744 [patent_app_country] => US [patent_app_date] => 2004-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 41 [patent_no_of_words] => 19696 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/407/07407661.pdf [firstpage_image] =>[orig_patent_app_number] => 10833744 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/833744
Methods and reagents that generate a CD8 T cell immune response Apr 27, 2004 Issued
Array ( [id] => 7018797 [patent_doc_number] => 20050220816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Mutant viral nucleic acids and vaccine containing same' [patent_app_type] => utility [patent_app_number] => 10/814689 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 21321 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20050220816.pdf [firstpage_image] =>[orig_patent_app_number] => 10814689 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/814689
Mutant viral nucleic acids and vaccine containing same Mar 30, 2004 Abandoned
Array ( [id] => 856942 [patent_doc_number] => 07375202 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-20 [patent_title] => 'Human virus causing severe acute respiratory syndrome (SARS) and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/808121 [patent_app_country] => US [patent_app_date] => 2004-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 90 [patent_figures_cnt] => 14 [patent_no_of_words] => 23876 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/375/07375202.pdf [firstpage_image] =>[orig_patent_app_number] => 10808121 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/808121
Human virus causing severe acute respiratory syndrome (SARS) and uses thereof Mar 23, 2004 Issued
Array ( [id] => 288899 [patent_doc_number] => 07547512 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-16 [patent_title] => 'High-throughput diagnostic assay for the human virus causing severe acute respiratory syndrome (SARS)' [patent_app_type] => utility [patent_app_number] => 10/807807 [patent_app_country] => US [patent_app_date] => 2004-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 106 [patent_figures_cnt] => 31 [patent_no_of_words] => 34004 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/547/07547512.pdf [firstpage_image] =>[orig_patent_app_number] => 10807807 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/807807
High-throughput diagnostic assay for the human virus causing severe acute respiratory syndrome (SARS) Mar 23, 2004 Issued
Array ( [id] => 5056884 [patent_doc_number] => 20070059806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection' [patent_app_type] => utility [patent_app_number] => 10/546034 [patent_app_country] => US [patent_app_date] => 2004-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 27737 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20070059806.pdf [firstpage_image] =>[orig_patent_app_number] => 10546034 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/546034
Nucleic acid molecules, polypeptides, antibodies and compositions for treating and detecting influenza virus infection Feb 23, 2004 Issued
Array ( [id] => 7261480 [patent_doc_number] => 20040241183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Human lymphocyte vaccine adjuvant' [patent_app_type] => new [patent_app_number] => 10/783259 [patent_app_country] => US [patent_app_date] => 2004-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6967 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20040241183.pdf [firstpage_image] =>[orig_patent_app_number] => 10783259 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/783259
Human lymphocyte medium adjuvant Feb 19, 2004 Issued
Array ( [id] => 7088532 [patent_doc_number] => 20050008644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Potentiation of the immune response' [patent_app_type] => utility [patent_app_number] => 10/778667 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3336 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20050008644.pdf [firstpage_image] =>[orig_patent_app_number] => 10778667 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/778667
Potentiation of the immune response Feb 12, 2004 Abandoned
Array ( [id] => 7446978 [patent_doc_number] => 20040186066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Method of treatment with nelfinavir' [patent_app_type] => new [patent_app_number] => 10/776568 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11753 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20040186066.pdf [firstpage_image] =>[orig_patent_app_number] => 10776568 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/776568
Method of treatment with nelfinavir Feb 9, 2004 Abandoned
Array ( [id] => 5807663 [patent_doc_number] => 20060094017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Immunogens for hiv vaccine' [patent_app_type] => utility [patent_app_number] => 10/544499 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7663 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094017.pdf [firstpage_image] =>[orig_patent_app_number] => 10544499 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/544499
Immunogens for hiv vaccine Feb 9, 2004 Abandoned
Array ( [id] => 922954 [patent_doc_number] => 07318926 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-15 [patent_title] => 'Glycosylated specificity exchangers' [patent_app_type] => utility [patent_app_number] => 10/773628 [patent_app_country] => US [patent_app_date] => 2004-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18745 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/318/07318926.pdf [firstpage_image] =>[orig_patent_app_number] => 10773628 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/773628
Glycosylated specificity exchangers Feb 4, 2004 Issued
Array ( [id] => 7677644 [patent_doc_number] => 20040152182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Viral particles released after infection by human cytomegalovirus, and their use as vaccine' [patent_app_type] => new [patent_app_number] => 10/770467 [patent_app_country] => US [patent_app_date] => 2004-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8018 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152182.pdf [firstpage_image] =>[orig_patent_app_number] => 10770467 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/770467
Viral particles released after infection by human cytomegalovirus, and their use as vaccine Feb 3, 2004 Abandoned
Array ( [id] => 7316726 [patent_doc_number] => 20040223977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Fusion peptide HIV vaccines' [patent_app_type] => new [patent_app_number] => 10/769991 [patent_app_country] => US [patent_app_date] => 2004-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7218 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20040223977.pdf [firstpage_image] =>[orig_patent_app_number] => 10769991 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/769991
Fusion peptide HIV vaccines Feb 2, 2004 Abandoned
Array ( [id] => 7423225 [patent_doc_number] => 20040265320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein' [patent_app_type] => new [patent_app_number] => 10/766528 [patent_app_country] => US [patent_app_date] => 2004-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19222 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265320.pdf [firstpage_image] =>[orig_patent_app_number] => 10766528 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/766528
Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein Jan 28, 2004 Abandoned
Array ( [id] => 7599707 [patent_doc_number] => 07582740 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-01 [patent_title] => 'Methods and kits for detecting SARS-associated coronavirus' [patent_app_type] => utility [patent_app_number] => 10/764075 [patent_app_country] => US [patent_app_date] => 2004-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 6 [patent_no_of_words] => 8854 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/582/07582740.pdf [firstpage_image] =>[orig_patent_app_number] => 10764075 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/764075
Methods and kits for detecting SARS-associated coronavirus Jan 22, 2004 Issued
Array ( [id] => 7303207 [patent_doc_number] => 20040115184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Methods and compositions for modifying apolipoprotein b mrna editing' [patent_app_type] => new [patent_app_number] => 10/468987 [patent_app_country] => US [patent_app_date] => 2004-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20992 [patent_no_of_claims] => 88 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115184.pdf [firstpage_image] =>[orig_patent_app_number] => 10468987 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/468987
Methods and compositions for modifying apolipoprotein b mrna editing Jan 8, 2004 Abandoned
Array ( [id] => 7468023 [patent_doc_number] => 20040198960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Human monoclonal antibodies against capsular polysaccharides of streptococcus pneumoniae' [patent_app_type] => new [patent_app_number] => 10/483447 [patent_app_country] => US [patent_app_date] => 2004-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10060 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198960.pdf [firstpage_image] =>[orig_patent_app_number] => 10483447 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/483447
Human monoclonal antibodies against capsular polysaccharides of streptococcus pneumoniae Jan 6, 2004 Abandoned
Array ( [id] => 6925799 [patent_doc_number] => 20050239054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Method and compositions for identifying anti-HIV therapeutic compounds' [patent_app_type] => utility [patent_app_number] => 10/740694 [patent_app_country] => US [patent_app_date] => 2003-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 401863 [patent_no_of_claims] => 180 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10740694 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/740694
Method and compositions for identifying anti-HIV therapeutic compounds Dec 21, 2003 Abandoned
Array ( [id] => 5776348 [patent_doc_number] => 20060104988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Vaccines against hiv-1 tat protein to generate neutralizing antibodies' [patent_app_type] => utility [patent_app_number] => 10/539677 [patent_app_country] => US [patent_app_date] => 2003-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17446 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20060104988.pdf [firstpage_image] =>[orig_patent_app_number] => 10539677 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/539677
Vaccines against hiv-1 tat protein to generate neutralizing antibodies Dec 17, 2003 Abandoned
Array ( [id] => 7318824 [patent_doc_number] => 20040224883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Compositions and methods for treating HIV infections' [patent_app_type] => new [patent_app_number] => 10/737288 [patent_app_country] => US [patent_app_date] => 2003-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19631 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224883.pdf [firstpage_image] =>[orig_patent_app_number] => 10737288 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/737288
Compositions and methods for treating HIV infections Dec 14, 2003 Abandoned
Menu